Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students

Douglas Cullinan, Kenneth D. Gadow, Michael H. Epstein

Research output: Contribution to journalArticle

26 Scopus citations


Psychotropic drug treatment in learning-disabled (LD), educable mentally retarded (EMR), and seriously emotionally disturbed (ED) children and adolescents receiving public school special education services was examined. The findings indicated that while treatment prevalence rates for EMR and ED groups were comparable, the rate for LD students was much lower. In the LD sample, pharmacotherapy was associated with higher ratings of behavioral deviance, longer placement in special education, less social integration, and greater peer rejection, which suggests that symptom severity is an important determiner of pharmacotherapy in this population.

Original languageEnglish (US)
Pages (from-to)469-477
Number of pages9
JournalJournal of Abnormal Child Psychology
Issue number4
Publication statusPublished - Dec 1 1987


ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this